| NCT ID | NCT02593565 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | Vasculitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2015-11 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2015-11 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online surveys to assess 1. each woman's vasculitis severity and pregnancy-related experiences, and 2. pregnancy outcomes.
Eligibility Criteria
Inclusion Criteria: 1. Women 18 years of age or older with one of the following diseases may take part in the study: * Behçet's disease; * Central nervous system (CNS) vasculitis; * Cryoglobulinemic vasculitis (Cryoglobulinemia); * Eosinophilic granulomatosis with polyangiitis (also called Churg-Strauss Syndrome); * Giant Cell (Temporal) Arteritis (GCA); * Granulomatosis with polyangiitis (also called Wegener's); * IgA vasculitis (Henoch-Schoenlein purpura); * Microscopic polyangiitis (MPA); * Polyarteritis nodosa (PAN); * Takayasu's arteritis (TAK); * Urticarial vasculitis; * Other/Suspected Diagnosis. 2. Women must be pregnant (self-report) at the time of enrollment into the registry. Exclusion Criteria: 1. Non-English speaking, with the exception of people who speak Spanish, Portuguese, Italian, or Turkish. 2. Unable to provide consent.
Contact & Investigator
Christine Yeung
✉ christine.yeung@pennmedicine.upenn.eduMegan Clowse, MD, MPH
STUDY CHAIR
Duke University
Frequently Asked Questions
Who can join the NCT02593565 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Vasculitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02593565 currently recruiting?
Yes, NCT02593565 is actively recruiting participants. Contact the research team at christine.yeung@pennmedicine.upenn.edu for enrollment information.
Where is the NCT02593565 trial being conducted?
This trial is being conducted at Tampa, United States.
Who is sponsoring the NCT02593565 clinical trial?
NCT02593565 is sponsored by University of Pennsylvania. The principal investigator is Megan Clowse, MD, MPH at Duke University. The trial plans to enroll 100 participants.